Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) – The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.


Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *